Pharmaceutical Executive
Guidelines on how innovators can assert patents to protect their products’ exclusivity while avoiding claims from competitors and the FTC that their conduct runs afoul of U.S. antitrust law.
Tony Pezzano
Advertisement
Articles by Tony Pezzano
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Trump Administration’s Leadership Carousel Across Key Agencies
2
FDA Approves Foundayo Under National Priority Voucher Program
3
The New Antitrust Era: Why CVS-Style Healthcare Integration is Now the FTC’s Primary Target
4
President Trump Imposes 100% Tariffs on Branded Pharmaceuticals
5